Vaginal Contraception With NuvaRing Decreases Symptoms and Uterine Features of Adenomyosis: A Prospective Evaluation
(Abstracted from Contraception 2025:150:111016, doi:10.1016/j.contraception.2025.111016) Adenomyosis occurs when ectopic endometrial glands invade the myometrium and can cause symptoms such as an enlarged uterus, heavy menstrual bleeding, pelvic pain, infertility, and pregnancy complications. It occurs in an estimated 20% of asymptomatic and 45% of symptomatic women, and risk factors for its development include age, endometriosis, multiple births, uterine surgery, spontaneous miscarriage, and cervical conditions.
Authors
- Anjeza Xholli (ORCID: https://orcid.org/0000-0001-8887-3823)
- Ambrogio Pietro Londero (ORCID: https://orcid.org/0000-0001-6429-1220)
- Francesca Oppedisano
- Angelo Cagnacci (ORCID: https://orcid.org/0000-0003-2714-623X)
- Mattia Francesco Ferraro (ORCID: https://orcid.org/0000-0001-8354-8845)
- Isabella Perugi (ORCID: https://orcid.org/0000-0001-8566-7127)
Institutions
- P and L (Czechia) (CZ)
Publication Details
- Journal
- Obstetrical & Gynecological Survey
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1097/01.ogx.0001176364.53087.c6
- Primary Topic
- Endometriosis Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00